Theriva Biologics, Inc. Cash
Theriva Biologics, Inc. (TOVX) had Cash of $15.50 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2025-11-12
- 2025-09-30: Cash $15.50M.
- 2023-09-30: Cash $26.10M.
- 2023-06-30: Cash $32.80M.
- 2019-11-30: Cash $17.60M.
| Period end | Cash |
|---|---|
| 2025-09-30 | $15.50M 10-Q · filed 2025-11-12 |
| 2023-09-30 | $26.10M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $32.80M 10-Q · filed 2023-08-08 |
| 2019-11-30 | $17.60M 10-Q · filed 2019-11-04 |
| 2013-09-30 | $5.14M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $6.88M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $8.52M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $9.95M 10-Q · filed 2013-11-14 |
| 2012-09-30 | $4.58M 10-Q · filed 2013-11-14 |
| 2012-06-30 | $5.93M 10-Q · filed 2013-08-14 |
| 2012-03-31 | $6.80M 10-Q · filed 2013-05-15 |
| 2011-12-31 | $6.68M 10-Q · filed 2013-11-14 |
| 2011-09-30 | $4.61M 10-Q · filed 2012-11-14 |
| 2011-06-30 | $8.39M 10-Q/A · filed 2012-09-11 |
| 2011-03-31 | $6.08M 10-Q · filed 2012-05-15 |
| 2010-12-31 | $2.65M 10-K · filed 2013-04-16 |
| 2009-12-31 | $2.71M 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |